■左甲状腺素是一种常见的处方药。许多药物和食物,然而,会干扰其生物利用度。这篇综述的目的是总结药物,与左甲状腺素相互作用的食品和饮料,并评估其效果,机制和治疗。
■对与左甲状腺素相互作用的干扰物质进行了系统评价。WebofScience,Embase,PubMed,科克伦图书馆,本研究检索了来自其他来源的灰色文献和参考文献列表,用于比较有和没有干扰物质的左甲状腺素疗效的人体研究.病人的特点,药物类,的影响和机制进行了提取。使用NHLBI研究质量评估工具和JBI关键评估清单来评估纳入研究的质量。
■共纳入107篇文章和128项研究。在钙和铁补充剂中揭示了药物的相互作用,质子泵抑制剂,胆汁酸螯合剂,磷酸盐粘合剂,性激素,抗惊厥药和其他药物。一些食品和饮料也会导致吸收不良。拟议的机制包括直接复合,碱化,血清甲状腺素结合球蛋白水平的改变和通过脱碘加速左甲状腺素分解代谢。剂量调整,给药分离和停止干扰物质可以消除相互作用。液体溶液和软凝胶胶囊可以消除由于螯合和碱化引起的吸收不良。大多数纳入研究的质量是中等的。
■许多药物和食物会损害左甲状腺素的生物利用度。临床医生,患者和制药公司应该意识到可能的相互作用。需要进一步精心设计的研究来提供更多关于治疗和机制的可靠证据。
UNASSIGNED: Levothyroxine is a common prescribed drug. Many medications and food, however, can interfere with its bioavailability. The aim of this
review was to summarize the medications, food and beverages that interact with levothyroxine and to assess their effects, mechanisms and treatments.
UNASSIGNED: A systematic
review on interfering substances that interact with levothyroxine was performed. Web of Science, Embase, PubMed, the Cochrane library, grey literature from other sources and the lists of references were searched for human studies comparing the levothyroxine efficacy with and without interfering substances. The patient characteristics, drug classes, effects and mechanism were extracted. The NHLBI study quality assessment tools and the JBI critical appraisal checklist were used to assess the quality of included studies.
UNASSIGNED: A total of 107 articles with 128 studies were included. Drugs interactions were revealed in calcium and iron supplements, proton pump inhibitors, bile acid sequestrants, phosphate binders, sex hormones, anticonvulsants and other drugs. Some food and beverage could also induce malabsorption. Proposed mechanisms included direct complexing, alkalization, alteration of serum thyroxine-binding globulin levels and acceleration of levothyroxine catabolism via deiodination. Dose adjustment, administration separation and discontinuation of interfering substances can eliminate the interactions. Liquid solutions and soft-gel capsules could eliminate the malabsorption due to chelation and alkalization. The qualities of most included studies were moderate.
UNASSIGNED: Lots of medications and food can impair the bioavailability of levothyroxine. Clinicians, patients and pharmaceutical companies should be aware of the possible interactions. Further well-designed studies are needed to provide more solid evidence on treatment and mechanisms.